Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
BiomX Inc. See All Filings	D	2026-01-20 16:01:22 UTC
Amount To Be Raised $3,300,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001739174 Filed Document 0001213900-26-005642 Exclusions or Exemptions 506b Accepted Date 2026-01-20 16:01:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Equity
BiomX Inc. See All Filings	D	2024-04-01 08:27:16 UTC
Amount To Be Raised $61,547,439 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. and RBC Capital Markets, LLC CIK Number 0001739174 Filed Document 0001213900-24-028241 Exclusions or Exemptions 506b Accepted Date 2024-04-01 08:27:16 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Equity
BiomX Inc. See All Filings	D	2023-03-03 16:09:04 UTC
Amount To Be Raised $7,484,390 Associated Brokers / Dealers None CIK Number 0001739174 Filed Document 0001213900-23-017225 Exclusions or Exemptions 506b Accepted Date 2023-03-03 16:09:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Equity
BiomX Inc. See All Filings	D	2022-01-04 16:01:33 UTC
Amount To Be Raised $4,998,293 Associated Brokers / Dealers None CIK Number 0001739174 Filed Document 0001213900-22-000469 Exclusions or Exemptions 506b Accepted Date 2022-01-04 16:01:33 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Equity
BiomX Inc. See All Filings	D	2021-10-25 08:43:09 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001739174 Filed Document 0001213900-21-054333 Exclusions or Exemptions 506b Accepted Date 2021-10-25 08:43:09 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Equity